- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Senores Pharma Subsidiary Secures Ukraine GMP Certification for Gujarat Manufacturing Facility

Ahmedabad: Senores Pharmaceuticals Limited has announced that its subsidiary, Ratnatris Pharmaceuticals Private Limited, has received Good Manufacturing Practices (GMP) certification under the Pharmaceutical Inspection Co-operation Scheme (PIC/S) for its manufacturing facility located in Mehsana, Gujarat.
The certification was granted by the State Service of Ukraine on Medicines and Drugs Control (SMDC), according to a regulatory filing submitted by the company.
The company informed the stock exchanges that the GMP compliance certificate was issued by the Ukrainian regulatory authority on November 16, 2026, and was received by the company on November 17, 2026.
With this certification, Senores Pharmaceuticals, through its subsidiary Ratnatris Pharmaceuticals, has expanded its pathway to pursue regulatory approvals across semi-regulated markets. The development is expected to support the company’s efforts to strengthen its regulatory presence and explore opportunities in additional international pharmaceutical markets.
The certification covers the manufacturing facility of Ratnatris Pharmaceuticals Private Limited in Mehsana, Gujarat. The recognition under the PIC/S GMP framework marks an important regulatory development for the subsidiary’s manufacturing operations.
Senores Pharmaceuticals Limited is headquartered in Ahmedabad, Gujarat.
M. Pharm (Pharmaceutics)
Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

